Benzinga's Top Upgrades, Downgrades For October 2, 2020

Upgrades

• According to Evercore ISI Group, the prior rating for Splunk Inc (NASDAQ: SPLK) was changed from In-Line to Outperform. Splunk earned $0.33 in the second quarter, compared to $0.67 in the year-ago quarter. The current stock performance of Splunk shows a 52-week-high of $225.89 and a 52-week-low of $93.92. Moreover, at the end of the last trading period, the closing price was at $192.56.
• According to B of A Securities, the prior rating for Nu Skin Enterprises Inc (NYSE: NUS) was changed from Underperform to Neutral. Nu Skin Enterprises earned $0.81 in the second quarter, compared to $0.83 in the year-ago quarter. The stock has a 52-week-high of $53.63 and a 52-week-low of $12.30. At the end of the last trading period, Nu Skin Enterprises closed at $51.17.
• According to Truist Securities, the prior rating for Medpace Holdings Inc (NASDAQ: MEDP) was changed from Hold to Buy. For the second quarter, Medpace Hldgs had an EPS of $0.64, compared to year-ago quarter EPS of $0.81. The stock has a 52-week-high of $144.49 and a 52-week-low of $58.72. At the end of the last trading period, Medpace Hldgs closed at $114.16.
• Susquehanna upgraded the previous rating for JB Hunt Transport Services Inc (NASDAQ: JBHT) from Neutral to Positive. JB Hunt Transport Servs earned $1.14 in the second quarter, compared to $1.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $144.34 and a 52-week-low of $75.29. JB Hunt Transport Servs closed at $125.21 at the end of the last trading period.
• For Immunogen Inc (NASDAQ: IMGN), Guggenheim upgraded the previous rating of Neutral to the current rating Buy. In the second quarter, Immunogen showed an EPS of $0.14, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $7.07 and a 52-week-low of $1.95. Immunogen closed at $3.70 at the end of the last trading period.
• For American Eagle Outfitters Inc (NYSE: AEO), B of A Securities upgraded the previous rating of Underperform to the current rating Neutral. In the second quarter, American Eagle Outfitters showed an EPS of $0.03, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of $16.82 and a 52-week-low of $6.54. American Eagle Outfitters closed at $14.91 at the end of the last trading period.
• For Carvana Co (NYSE: CVNA), Morgan Stanley upgraded the previous rating of Underweight to the current rating Equal-Weight. In the second quarter, Carvana showed an EPS of $0.62, compared to $0.40 from the year-ago quarter. The current stock performance of Carvana shows a 52-week-high of $242.15 and a 52-week-low of $22.16. Moreover, at the end of the last trading period, the closing price was at $237.67.
• For Donaldson Co Inc (NYSE: DCI), Baird upgraded the previous rating of Neutral to the current rating Outperform. In the fourth quarter, Donaldson showed an EPS of $0.50, compared to $0.61 from the year-ago quarter. At the moment, the stock has a 52-week-high of $58.32 and a 52-week-low of $31.08. Donaldson closed at $46.92 at the end of the last trading period.
• For Six Flags Entertainment Corp (NYSE: SIX), Goldman Sachs upgraded the previous rating of Sell to the current rating Neutral. Six Flags Entertainment earned $1.62 in the second quarter, compared to $0.99 in the year-ago quarter. The current stock performance of Six Flags Entertainment shows a 52-week-high of $53.00 and a 52-week-low of $8.75. Moreover, at the end of the last trading period, the closing price was at $19.96.
• For Workday Inc (NASDAQ: WDAY), Stifel upgraded the previous rating of Hold to the current rating Buy. For the second quarter, Workday had an EPS of $0.84, compared to year-ago quarter EPS of $0.44. The stock has a 52-week-high of $248.75 and a 52-week-low of $107.75. At the end of the last trading period, Workday closed at $220.52.
• According to DZ Bank, the prior rating for Walmart Inc (NYSE: WMT) was changed from Hold to Buy. For the second quarter, Walmart had an EPS of $1.56, compared to year-ago quarter EPS of $1.27. The stock has a 52-week-high of $151.33 and a 52-week-low of $102.00. At the end of the last trading period, Walmart closed at $143.07.
• According to Evercore ISI Group, the prior rating for CSX Corp (NASDAQ: CSX) was changed from In-Line to Outperform. In the second quarter, CSX showed an EPS of $0.65, compared to $1.08 from the year-ago quarter. The current stock performance of CSX shows a 52-week-high of $81.40 and a 52-week-low of $46.81. Moreover, at the end of the last trading period, the closing price was at $76.86.
• Raymond James upgraded the previous rating for Targa Resources Corp (NYSE: TRGP) from Outperform to Strong Buy. In the second quarter, Targa Resources showed an EPS of $0.21, compared to $0.18 from the year-ago quarter. The stock has a 52-week-high of $42.12 and a 52-week-low of $3.66. At the end of the last trading period, Targa Resources closed at $13.58.

Downgrades

• Susquehanna downgraded the previous rating for Landstar System Inc (NASDAQ: LSTR) from Positive to Neutral. For the second quarter, Landstar System had an EPS of $0.68, compared to year-ago quarter EPS of $1.53. The stock has a 52-week-high of $139.99 and a 52-week-low of $85.30. At the end of the last trading period, Landstar System closed at $125.18.
• According to HC Wainwright & Co., the prior rating for AMAG Pharmaceuticals Inc (NASDAQ: AMAG) was changed from Buy to Neutral. For the second quarter, AMAG Pharmaceuticals had an EPS of $0.57, compared to year-ago quarter EPS of $1.14. The stock has a 52-week-high of $13.80 and a 52-week-low of $4.41. At the end of the last trading period, AMAG Pharmaceuticals closed at $13.65.
• Wells Fargo downgraded the previous rating for DexCom Inc (NASDAQ: DXCM) from Equal-Weight to Underweight. DexCom earned $0.79 in the second quarter, compared to $0.08 in the year-ago quarter. The current stock performance of DexCom shows a 52-week-high of $456.23 and a 52-week-low of $145.23. Moreover, at the end of the last trading period, the closing price was at $413.84.
• For General Dynamics Corp (NYSE: GD), Baird downgraded the previous rating of Outperform to the current rating Neutral. For the second quarter, General Dynamics had an EPS of $2.18, compared to year-ago quarter EPS of $2.77. At the moment, the stock has a 52-week-high of $190.08 and a 52-week-low of $100.55. General Dynamics closed at $138.22 at the end of the last trading period.

Initiations

• SVB Leerink initiated coverage on Immunic Inc (NASDAQ: IMUX) with an Outperform rating. The price target for Immunic is set to $45.00. In the second quarter, Immunic showed an EPS of $0.90, compared to $1.52 from the year-ago quarter. The stock has a 52-week-high of $23.39 and a 52-week-low of $4.19. At the end of the last trading period, Immunic closed at $18.87.
• Benchmark initiated coverage on Fortress Biotech Inc (NASDAQ: FBIO) with a Buy rating. The price target for Fortress Biotech is set to $9.00. Fortress Biotech earned $0.05 in the second quarter, compared to $0.51 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.78 and a 52-week-low of $1.04. Fortress Biotech closed at $4.03 at the end of the last trading period.
• With a current rating of Equal-Weight, Barclays initiated coverage on Shaw Communications Inc (NYSE: SJR). The price target seems to have been set at $21.00 for Shaw Communications. In the third quarter, Shaw Communications showed an EPS of $0.27, compared to $0.33 from the year-ago quarter. The current stock performance of Shaw Communications shows a 52-week-high of $20.90 and a 52-week-low of $12.20. Moreover, at the end of the last trading period, the closing price was at $18.31.
• For Rogers Communications Inc (NYSE: RCI), Barclays initiated coverage, by setting the current rating at Equal-Weight. Rogers Communications earned $0.43 in the second quarter, compared to $0.88 in the year-ago quarter. The stock has a 52-week-high of $51.29 and a 52-week-low of $32.20. At the end of the last trading period, Rogers Communications closed at $39.80.
• Bernstein initiated coverage on Humana Inc (NYSE: HUM) with a Market Perform rating. The price target for Humana is set to $459.00. Humana earned $12.56 in the second quarter, compared to $6.05 in the year-ago quarter. The stock has a 52-week-high of $431.12 and a 52-week-low of $208.25. At the end of the last trading period, Humana closed at $415.07.
• Raymond James initiated coverage on GoHealth Inc (NASDAQ: GOCO) with an Outperform rating. The price target for GoHealth is set to $18.00. GoHealth earned $0.07 in the second quarter. The current stock performance of GoHealth shows a 52-week-high of $20.47 and a 52-week-low of $12.22. Moreover, at the end of the last trading period, the closing price was at $13.72.
• With a current rating of Outperform, SVB Leerink initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ: XENE). The price target seems to have been set at $22.00 for Xenon Pharmaceuticals. For the second quarter, Xenon Pharmaceuticals had an EPS of $0.00, compared to year-ago quarter EPS of $0.37. The current stock performance of Xenon Pharmaceuticals shows a 52-week-high of $18.45 and a 52-week-low of $7.00. Moreover, at the end of the last trading period, the closing price was at $11.19.
• Stifel initiated coverage on Evofem Biosciences Inc (NASDAQ: EVFM) with a Buy rating. The price target for Evofem Biosciences is set to $5.00. Evofem Biosciences earned $0.39 in the second quarter, compared to $0.95 in the year-ago quarter. The stock has a 52-week-high of $7.50 and a 52-week-low of $1.91. At the end of the last trading period, Evofem Biosciences closed at $2.39.
• BMO Capital initiated coverage on TechnipFMC PLC (NYSE: FTI) with a Market Perform rating. The price target for TechnipFMC is set to $7.50. TechnipFMC earned $0.09 in the second quarter, compared to $0.39 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.14 and a 52-week-low of $4.49. TechnipFMC closed at $6.27 at the end of the last trading period.
• BMO Capital initiated coverage on Halliburton Co (NYSE: HAL) with a Market Perform rating. The price target for Halliburton is set to $14.00. For the second quarter, Halliburton had an EPS of $0.05, compared to year-ago quarter EPS of $0.35. At the moment, the stock has a 52-week-high of $25.47 and a 52-week-low of $4.25. Halliburton closed at $11.17 at the end of the last trading period.
• Loop Capital initiated coverage on Papa John's International Inc (NASDAQ: PZZA) with a Buy rating. The price target for Papa John's International is set to $110.00. Papa John's International earned $0.48 in the second quarter, compared to $0.28 in the year-ago quarter. The current stock performance of Papa John's International shows a 52-week-high of $102.25 and a 52-week-low of $28.55. Moreover, at the end of the last trading period, the closing price was at $83.33.
• With a current rating of Buy, Loop Capital initiated coverage on Shake Shack Inc (NYSE: SHAK). The price target seems to have been set at $78.00 for Shake Shack. Shake Shack earned $0.45 in the second quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $97.93 and a 52-week-low of $30.01. Shake Shack closed at $64.92 at the end of the last trading period.
• With a current rating of Outperform, BMO Capital initiated coverage on Schlumberger Ltd (NYSE: SLB). The price target seems to have been set at $21.00 for Schlumberger. Schlumberger earned $0.05 in the second quarter, compared to $0.35 in the year-ago quarter. At the moment, the stock has a 52-week-high of $41.14 and a 52-week-low of $11.87. Schlumberger closed at $15.02 at the end of the last trading period.
• With a current rating of Market Perform, Bernstein initiated coverage on Snowflake Inc (NYSE: SNOW). The price target seems to have been set at $270.00 for Snowflake. At the moment, the stock has a 52-week-high of $278.26 and a 52-week-low of $208.55. Snowflake closed at $243.35 at the end of the last trading period.
• Jefferies initiated coverage on Unum Therapeutics Inc (NASDAQ: UMRX) with a Buy rating. The price target for Unum Therapeutics is set to $4.00. Unum Therapeutics earned $0.24 in the second quarter, compared to $0.34 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.72 and a 52-week-low of $0.29. Unum Therapeutics closed at $2.26 at the end of the last trading period.